Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29156Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Vermersch, P. | - |
| dc.contributor.author | Baker, M. | - |
| dc.contributor.author | Bass, A. D. | - |
| dc.contributor.author | Berkovich, R. | - |
| dc.contributor.author | Comi, G. | - |
| dc.contributor.author | Eichau, S. | - |
| dc.contributor.author | Graves, D. | - |
| dc.contributor.author | Hunter, S. F. | - |
| dc.contributor.author | Ionete, C. | - |
| dc.contributor.author | Limmroth, V. | - |
| dc.contributor.author | Meuth, S. G. | - |
| dc.contributor.author | Naismith, R. T. | - |
| dc.contributor.author | Sharrack, B. | - |
| dc.contributor.author | Subei, A. | - |
| dc.contributor.author | Daizadeh, N. | - |
| dc.contributor.author | Choudhry, Z. | - |
| dc.contributor.author | VAN WIJMEERSCH, Bart | - |
| dc.date.accessioned | 2019-09-12T10:56:20Z | - |
| dc.date.available | 2019-09-12T10:56:20Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | EUROPEAN JOURNAL OF NEUROLOGY, 26(SI), p. 866-867 | - |
| dc.identifier.issn | 1351-5101 | - |
| dc.identifier.uri | http://hdl.handle.net/1942/29156 | - |
| dc.description.sponsorship | Study supported by Sanofi and Bayer HealthCare Pharmaceuticals. | - |
| dc.language.iso | en | - |
| dc.publisher | WILEY | - |
| dc.title | Use of other disease-modifying therapies after or between alemtuzumab treatments: pooled results from the CAMMS223, and CARE-MS I and II studies over 8 years | - |
| dc.type | Journal Contribution | - |
| local.bibliographicCitation.conferencedate | JUN 29-JUL 02, 2019 | - |
| local.bibliographicCitation.conferencename | 5th Congress of the European-Academy-of-Neurology (EAN) | - |
| local.bibliographicCitation.conferenceplace | Oslo, NORWAY | - |
| dc.identifier.epage | 867 | - |
| dc.identifier.issue | SI | - |
| dc.identifier.spage | 866 | - |
| dc.identifier.volume | 26 | - |
| local.format.pages | 2 | - |
| local.bibliographicCitation.jcat | M | - |
| dc.description.notes | [Vermersch, P.] Univ Lille, Lille, France. [Baker, M.] Collier Neurol Specialists, Naples, FL USA. [Bass, A. D.] Neurol Ctr San Antonio, San Antonio, TX USA. [Berkovich, R.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Eichau, S.] Hosp Univ Virgen Macarena, Seville, Spain. [Graves, D.] Atrium Hlth, Neurosci Inst Neurol, Charlotte, NC USA. [Hunter, S. F.] Adv Neurosci Inst, Franklin, TN USA. [Ionete, C.] Univ Massachusetts, Mem Med Ctr, Worcester, MA 01605 USA. [Limmroth, V.] Klin Neurol & Palliat Med, Cologne, Germany. [Meuth, S. G.] Univ Munster, Munster, Germany. [Naismith, R. T.] Washington Univ, Sch Med, St Louis, MO USA. [Sharrack, B.] Univ Sheffield, Sheffield, S Yorkshire, England. [Sharrack, B.] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England. [Subei, A.] Mem Healthcare Syst, Hollywood, FL USA. [Daizadeh, N.; Choudhry, Z.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium. | - |
| local.publisher.place | HOBOKEN | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Meeting Abstract | - |
| dc.identifier.isi | 000474481004026 | - |
| item.accessRights | Closed Access | - |
| item.fulltext | No Fulltext | - |
| item.contributor | Vermersch, P. | - |
| item.contributor | Baker, M. | - |
| item.contributor | Bass, A. D. | - |
| item.contributor | Berkovich, R. | - |
| item.contributor | Comi, G. | - |
| item.contributor | Eichau, S. | - |
| item.contributor | Graves, D. | - |
| item.contributor | Hunter, S. F. | - |
| item.contributor | Ionete, C. | - |
| item.contributor | Limmroth, V. | - |
| item.contributor | Meuth, S. G. | - |
| item.contributor | Naismith, R. T. | - |
| item.contributor | Sharrack, B. | - |
| item.contributor | Subei, A. | - |
| item.contributor | Daizadeh, N. | - |
| item.contributor | Choudhry, Z. | - |
| item.contributor | VAN WIJMEERSCH, Bart | - |
| item.fullcitation | Vermersch, P.; Baker, M.; Bass, A. D.; Berkovich, R.; Comi, G.; Eichau, S.; Graves, D.; Hunter, S. F.; Ionete, C.; Limmroth, V.; Meuth, S. G.; Naismith, R. T.; Sharrack, B.; Subei, A.; Daizadeh, N.; Choudhry, Z. & VAN WIJMEERSCH, Bart (2019) Use of other disease-modifying therapies after or between alemtuzumab treatments: pooled results from the CAMMS223, and CARE-MS I and II studies over 8 years. In: EUROPEAN JOURNAL OF NEUROLOGY, 26(SI), p. 866-867. | - |
| crisitem.journal.issn | 1351-5101 | - |
| crisitem.journal.eissn | 1468-1331 | - |
| Appears in Collections: | Research publications | |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.